Clinical Scorecard: Washington Watch: New Congress, New Administration
At a Glance
| Category | Detail |
|---|---|
| Condition | |
| Key Mechanisms | Advocacy for ASC payment updates, lobbying against in-office cataract surgery payments, and promoting new quality measures. |
| Target Population | |
| Care Setting |
Key Highlights
- ASC payment rates updated by 2.9% in 2025
- Successful lobbying against payment for in-office cataract surgery, emphasizing patient safety concerns
- Withdrawal of significant payment limitations on MIGS procedures due to advocacy efforts
- New quality measures added to the ASC Quality Reporting Program, including those for TASS
- Ongoing advocacy for patient health and safety standards in office surgeries
Guideline-Based Recommendations
Diagnosis
- Continued assessment of patient comorbidities associated with cataract surgery
Management
- Advocate for the maintenance of the Hospital Market Basket for ASC payment updates
- Recommend implementation of new ASC quality measures for TASS
Monitoring & Follow-up
- Monitor the implementation of ASC quality measures and their impact on patient outcomes
Risks
- Potential compromise of patient health and safety in unregulated office surgical suites
Patient & Prescribing Data
Emphasis on rigorous health and safety standards in ASCs compared to office settings, highlighting specific deficiencies in office settings.
Clinical Best Practices
- Support OOSS initiatives for legislative and regulatory advocacy
- Engage in grassroots lobbying to influence policy changes
- Ensure compliance with ASC quality measures to enhance patient safety, including specific protocols for anesthesia and emergency care.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.